Clinical Trials Browser

Phase 1/2 × Unknown × Nivolumab × Clear all

NCT03638375 2023-12-12

ACTME

Phase 1/2 Unknown

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT04981899 2023-04-12

NICE-40

Phase 1/2 Unknown

Hodgkin Disease

NCT05175235 2023-03-03

Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements

Phase 1/2 Unknown

Neoplasms

NCT03995017 2023-02-01

RiME

Phase 1/2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Stomach Neoplasms

NCT03682276 2022-12-13

PRIME-HCC

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT05027204 2022-10-13

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)

Phase 1/2 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT03825367 2022-10-12

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT05468294 2022-07-21

Nivokin

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05265650 2022-07-19

Noelia

Phase 1/2 Unknown

Non-Small Cell Lung Cancer Metastatic

NCT03374839 2022-05-06

Nivo-TIL

Phase 1/2 Unknown

Melanoma

NCT03161756 2022-04-07

CHARLI

Phase 1/2 Unknown

Melanoma

NCT05236608 2022-03-25

ADIVO Lung

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05162118 2022-03-09

Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer

Phase 1/2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

NCT04233840 2022-01-27

P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT04620954 2021-12-01

ORION-02

Phase 1/2 Unknown

Carcinoma, Ovarian Epithelial

NCT02948348 2021-09-16

Study to Nivolumab Following Preoperative Chemoradiotherapy

Phase 1/2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04061863 2021-09-08

KORNELIA

Phase 1/2 Unknown

Breast Neoplasms

NCT04521075 2021-08-16

A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC

Phase 1/2 Unknown

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02913417 2021-04-19

Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

Phase 1/2 Unknown

Uveal Melanoma

NCT04021420 2020-08-20

SONIMEL01

Phase 1/2 Unknown

Melanoma

NCT03993626 2019-06-21

CAROSELL

Phase 1/2 Unknown

Gastrointestinal

Colonic Neoplasms

NCT03792724 2019-01-03

INTRUST

Phase 1/2 Unknown

Neoplasms

NCT03311789 2017-10-17

Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Neoplasms